AAAAAA

   
Results: 1-1 |
Results: 1
LONG-TERM FOLLOW-UP ON THE TREATMENT OF ENDOMETRIOSIS WITH THE GNRH-AGONIST BUSERELINACETATE - LONG-TERM FOLLOW-UP DATA (UP TO 98 MONTHS) OF 42 PATIENTS WITH ENDOMETRIOSIS WHO WERE TREATED WITH GNRH-AGONIST BUSERELINACETATE (SUPRECUR(R)), WERE EVALUATED IN RESPECT OF RECURRENCE OF PAIN SYMPTOMS AND PREGNANCY OUTCOME
Authors: REGIDOR PA REGIDOR M KATO K BIER UW BUHLER K SCHINDLER AE
Citation: Pa. Regidor et al., LONG-TERM FOLLOW-UP ON THE TREATMENT OF ENDOMETRIOSIS WITH THE GNRH-AGONIST BUSERELINACETATE - LONG-TERM FOLLOW-UP DATA (UP TO 98 MONTHS) OF 42 PATIENTS WITH ENDOMETRIOSIS WHO WERE TREATED WITH GNRH-AGONIST BUSERELINACETATE (SUPRECUR(R)), WERE EVALUATED IN RESPECT OF RECURRENCE OF PAIN SYMPTOMS AND PREGNANCY OUTCOME, European journal of obstetrics, gynecology, and reproductive biology, 73(2), 1997, pp. 153-160
Risultati: 1-1 |